Literature DB >> 32649068

More on Covid-19 in Immune-Mediated Inflammatory Diseases.

Luigi Naldi1, Simone Cazzaniga1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32649068     DOI： 10.1056/NEJMc2018011

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19.

Authors:  Hong Zhou; Wei-Jian Ni; Wei Huang; Zhen Wang; Ming Cai; Yan-Cai Sun
Journal:  Front Immunol       Date:  2022-04-05       Impact factor: 8.786

2.  Administrative data and scientific evidence: a lesson from France - the safety of systemic treatment for psoriasis during the COVID-19 pandemic.

Authors:  S Cazzaniga; L Naldi
Journal:  Br J Dermatol       Date:  2021-11-02       Impact factor: 11.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.